ArticlePharmaceutics2022

Prevention of Ulcerative Colitis by Autologous Metabolite Transfer from Colitogenic Microbiota Treated with Lipid Nanoparticles Encapsulating an Anti-Inflammatory Drug Candidate.

Chunhua Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.